Subscribe: MedWorm: Trichomonas
http://www.medworm.com/rss/medicalfeeds/infectiousdiseases/Trichomonas.xml
Preview: MedWorm: Trichomonas

MedWorm: Trichomonas News



MedWorm.com provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Trichomonas



Last Build Date: Thu, 15 Mar 2018 08:24:30 +0100

 



Large racial and ethnic disparity in world's most common STI

Thu, 15 Mar 2018 04:00:00 +0100

(Johns Hopkins Medicine) In a new Johns Hopkins study, researchers have added to evidence that Trichomonas vaginalis (TV), the world's most common curable sexually transmitted infection (STI), disproportionately affects the black community. (Source: EurekAlert! - Medicine and Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




The STD You've Probably Never Heard Of

Mon, 07 Nov 2016 23:10:09 +0100

The Basics Trichomoniasis (trich) is a common STI caused by a tiny parasite called Trichomonas vaginalis. An estimated 3.7 million people are infected, but because only about 30 percent show symptoms, most people don't know they have it until they get a positive test result. How You Get It The parasite gets passed during unprotected vaginal sex (can be from penis to vagina, vagina to penis, or vagina to vagina). Trich usually doesn't affect other areas, like the mouth or anus, which means this is one STD that is relatively uncommon for gay and bisexual men. What's It Like? Here's where the not-fun part comes in: When trichomoniasis does cause symptoms, they're not exactly pleasant. Men may feel itching or irritation inside the penis, whereas women can experience a gross-smelling vaginal di...



Update on Laboratory Diagnosis and Epidemiology of Trichomonas vaginalis: You Can Teach an “Old” Dog “New” Trichs

Fri, 07 Oct 2016 13:43:43 +0100

Past viewpoints on Trichomonas vaginalis infection have characterized the associated clinical disease as a “nuisance” condition, with affected demographics largely being older African American females residing in urban centers. The advent of commercial molecular assays specific for T. vaginalis has offered a new outlook on trichomoniasis. Within high-prevalence sexually transmitted infection populati ons, parasite distribution is not localized to specific population centers, and T. vaginalis prevalence is elevated among both younger and older age groups. (Source: Clinical Microbiology Newsletter)



Trichomonas vaginalis Infection Among Homeless Adult WomenTrichomonas vaginalis Infection Among Homeless Adult Women

Thu, 14 Jul 2016 05:17:27 +0100

What is the prevalence of Trichomonas vaginalis infection among homeless women? Sexually Transmitted Infections (Source: Medscape Today Headlines)



Synedgen’s Director for Pharmaceutical Manufacturing Publishes New...

Tue, 01 Sep 2015 16:20:08 +0100

Study suggests that anti-retroviral lectins have a modest potential for preventing or treating Trichomonas infections(PRWeb September 01, 2015)Read the full story at http://www.prweb.com/releases/2015/09/prweb12934948.htm (Source: PRWeb: Medical Pharmaceuticals)



Class II Special Controls Guideline: Nucleic Acid Amplification Assays for the Detection of Trichomonas vaginalis - Guideline for Industry and Food and Drug Administration Staff

Tue, 18 Aug 2015 04:00:00 +0100

This guideline identifies measures that FDA believes will mitigate the risks to health associated with these devices and provide a reasonable assurance of safety and effectiveness. (Source: Food and Drug Adminstration (FDA): CDRHNew)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Federal Register: Medical Devices; Immunology and Microbiology Devices; Classification of Trichomonas Vaginalis Nucleic Acid Assay

Tue, 04 Aug 2015 04:00:00 +0100

The FDA is classifying a Trichomonas vaginalis nucleic acid assay into class II (special controls). The Agency is classifying the device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device. (Source: Food and Drug Adminstration (FDA): CDRHNew)



Bristol undergraduates publish parasite research

Tue, 28 Jul 2015 09:06:00 +0100

A team of University of Bristol undergraduates have published a study on genetic diversity in the sexually transmitted parasite Trichomonas vaginalis that they carried out as part of project work for their degrees in the School of Biological Sciences. (Source: University of Bristol news)



Could sex with 21 women 'cut prostate risk'?

Wed, 29 Oct 2014 10:30:00 +0100

ConclusionThis case-control study has suggested that having several female partners over a man’s lifetime is associated with a protective effect against prostate cancer, whereas having several male partners increased the risk.However, case-control studies like this one cannot prove that having several female partners reduces the risk of prostate cancer, or that having more male partners increases risk. When it comes to complex issues such as lifestyle, sexuality and cancer outcomes, there could be a wide range of contributing factors.If having multiple female partners reduced prostate cancer risk, it would be expected that the more partners you had the lower your risk would be. However, this study did not find such a relationship between number of female partners and associated risk. The...



STD may heighten risk of prostate cancer

Wed, 28 May 2014 03:02:38 +0100

Could a common sexually transmitted infection boost a man’s risk for prostate cancer? In a new study, Patricia Johnson, a professor of microbiology, immunology and molecular genetics at the David Geffen School of Medicine at UCLA, explored the connection between prostate cancer and the parasite that causes trichomoniasis, the most common non-viral sexually transmitted infection in men and women. Johnson’s team discovered that the parasite, Trichomonas vaginalis, secretes a protein that stimulates the growth of prostate cells and also induces an inflammatory response, which the researchers suspect enhances the cells’ progression to tumor cells. According to the Centers for Disease Control, an estimated 275 million people worldwide have the parasite, including about 3.7 million in the ...



Prostate cancer linked to common STI

Wed, 21 May 2014 11:26:00 +0100

“Prostate cancer could be a sexually transmitted disease caused by a common infection,” The Independent reports. Researchers have found evidence of a link between the cancer and trichomoniasis – a common parasite that is passed on during unprotected sexual contact. A laboratory study found the parasite produces a protein similar to a human protein that is necessary for the immune system to function. However, the human protein had also been shown to be involved in the growth of cancers, as it causes inflammation. This is of potential concern as trichomoniasis causes no noticeable symptoms in up to half of men. These men may then be subject to chronic inflammation without realising it. The study found that in the laboratory setting, the protein from the parasite acted on human blood c...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Management Challenges in Trichomonas vaginalis InfectionManagement Challenges in Trichomonas vaginalis Infection

Mon, 07 Oct 2013 13:05:21 +0100

What are the optimal methods of diagnosis and treatment for Trichomonas vaginalis? Sexually Transmitted Infections (Source: Medscape Today Headlines)



FDA approval and launch

Thu, 29 Aug 2013 11:28:50 +0100

BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has announced the US Food and Drug Administration clearance and launch of the BD ProbeTec™ Trichomonas vaginalis Qx Amplified DNA Assay for the direct qualitative detection of T. vaginalis DNA in endocervical and vaginal samples as well as neat urine specimens to aid in the diagnosis of trichomoniasis on the BD Viper™ System with XTR™ Technology. You must sign in to continue reading this article Hide related content:  Show related content read more (Source: Pharmacy Europe)



BD ProbeTec(TM) Trichomonas vaginalis Q(x) Assay Launches on the BD Viper(TM) System with XTR(TM) Technology in the United States

Tue, 27 Aug 2013 16:12:46 +0100

New Molecular Test Available to Diagnose Trichomonas vaginalis in Asymptomatic and Symptomatic Females BALTIMORE, Aug. 27, 2013 -- (Healthcare Sales & Marketing Network) -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (BDX), a leadin... Diagnostics, FDA, Product LaunchBD Diagnostics, BD , ProbeTec, trichomoniasis (Source: HSMN NewsFeed)



Researchers Identify Two Bacterial Communities Associated With Trichomonas Infection

Mon, 08 Apr 2013 18:00:00 +0100

A parasite that commonly causes sexually transmitted infections among women "cultivates" specific bacteria, according to new research carried out by David H. Martin, MD, Professor and Chief of Infectious Diseases at LSU Health Sciences Center New Orleans and his team. The parasite, called Trichomonas vaginalis is a fairly common sexually transmitted infection (STI) of the urogenital tract among women, affecting more than 160 million females around the world... (Source: Health News from Medical News Today)



Bill Gates’s $100,000 Condom Challenge

Wed, 27 Mar 2013 19:19:30 +0100

WebMD Medical News By Tim Locke Reviewed by Rob Hicks, MD March 25,  2013 — The Bill & Melinda Gates Foundation is offering a $100,000 grant to anyone who can develop what’s being called the next generation of condom. The aim is to help curb unwanted pregnancies and the spread of sexually transmitted infections around the world. The Condom of the Future The foundation’s Grand Challenges in Global Health initiative says it is looking for the next-generation condom that “significantly preserves or enhances pleasure, in order to improve uptake and regular use.” This could mean safe, new materials to “preserve or enhance sensation.” Most condoms are made of latex. Other important features include making male and female condoms easier to use (...

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.